Boiron SA Cash Flow Conversion Efficiency
Boiron SA cash flow conversion efficiency. Based on the latest financial reports, Boiron SA (BOI) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€27.52 Million ≈ $32.17 Million USD) by net assets (€392.78 Million ≈ $459.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Boiron SA (2001–2025)
Cash flow conversion efficiency of Boiron SA from 2001 to 2025. This chart illustrates how Boiron SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Boiron SA (BOI) stock price for real-time trading data and today's change.
Boiron SA Cash Flow Conversion Ratio Explained
Boiron SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Boiron SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boiron SA ranked by their cash flow conversion efficiency. Also see Boiron SA stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Choil Aluminum
KO:018470
|
-0.095x |
|
Jiaxing ZMAX Optech Co. Ltd. A
SHG:688307
|
N/A |
|
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
|
0.027x |
|
Samhi Hotels Limited
NSE:SAMHI
|
0.090x |
|
TrueLight
TWO:3234
|
-0.033x |
|
Zota Health Care LImited
NSE:ZOTA
|
-0.157x |
|
Suzhou Kelida Bldg &
SHG:603828
|
0.085x |
|
Dare Technology Co Ltd
SHE:000910
|
0.003x |
Annual Cash Flow Conversion Efficiency for Boiron SA (2001–2025)
The table below shows the annual cash flow conversion efficiency of Boiron SA from 2001 to 2025. Review BOI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €392.78 Million ≈ $459.20 Million |
€53.24 Million ≈ $62.24 Million |
0.136x | +29.67% |
| 2024-12-31 | €378.18 Million ≈ $442.14 Million |
€39.53 Million ≈ $46.22 Million |
0.105x | -10.04% |
| 2023-12-31 | €391.50 Million ≈ $457.70 Million |
€45.49 Million ≈ $53.18 Million |
0.116x | +10.35% |
| 2022-12-31 | €557.35 Million ≈ $651.60 Million |
€58.69 Million ≈ $68.61 Million |
0.105x | +68.07% |
| 2021-12-31 | €531.77 Million ≈ $621.70 Million |
€33.32 Million ≈ $38.95 Million |
0.063x | -53.27% |
| 2020-12-31 | €509.17 Million ≈ $595.27 Million |
€68.27 Million ≈ $79.81 Million |
0.134x | +33.25% |
| 2019-12-31 | €505.46 Million ≈ $590.94 Million |
€50.86 Million ≈ $59.46 Million |
0.101x | -41.95% |
| 2018-12-31 | €486.04 Million ≈ $568.24 Million |
€84.25 Million ≈ $98.50 Million |
0.173x | -14.36% |
| 2017-12-31 | €517.49 Million ≈ $605.00 Million |
€104.75 Million ≈ $122.46 Million |
0.202x | -13.69% |
| 2016-12-31 | €469.60 Million ≈ $549.01 Million |
€110.13 Million ≈ $128.75 Million |
0.235x | -5.42% |
| 2015-12-31 | €416.04 Million ≈ $486.40 Million |
€103.16 Million ≈ $120.61 Million |
0.248x | -2.04% |
| 2014-12-31 | €379.88 Million ≈ $444.12 Million |
€96.16 Million ≈ $112.42 Million |
0.253x | -7.32% |
| 2013-12-31 | €391.86 Million ≈ $458.12 Million |
€107.02 Million ≈ $125.11 Million |
0.273x | +9.17% |
| 2012-12-31 | €354.16 Million ≈ $414.05 Million |
€88.59 Million ≈ $103.58 Million |
0.250x | +56.78% |
| 2011-12-31 | €368.65 Million ≈ $430.99 Million |
€58.82 Million ≈ $68.77 Million |
0.160x | +6.24% |
| 2010-12-31 | €343.84 Million ≈ $401.99 Million |
€51.64 Million ≈ $60.37 Million |
0.150x | -41.34% |
| 2009-12-31 | €313.28 Million ≈ $366.25 Million |
€80.20 Million ≈ $93.76 Million |
0.256x | +6.15% |
| 2008-12-31 | €271.49 Million ≈ $317.40 Million |
€65.48 Million ≈ $76.55 Million |
0.241x | +7.40% |
| 2007-12-31 | €249.94 Million ≈ $292.21 Million |
€56.13 Million ≈ $65.62 Million |
0.225x | +33.97% |
| 2006-12-31 | €230.09 Million ≈ $268.99 Million |
€38.57 Million ≈ $45.09 Million |
0.168x | -7.68% |
| 2005-12-31 | €229.88 Million ≈ $268.75 Million |
€41.74 Million ≈ $48.80 Million |
0.182x | -23.95% |
| 2004-12-31 | €144.09 Million ≈ $168.46 Million |
€34.40 Million ≈ $40.22 Million |
0.239x | -2.79% |
| 2003-12-31 | €149.53 Million ≈ $174.82 Million |
€36.73 Million ≈ $42.94 Million |
0.246x | -4.17% |
| 2002-12-31 | €134.47 Million ≈ $157.20 Million |
€34.46 Million ≈ $40.29 Million |
0.256x | -8.21% |
| 2001-12-31 | €119.17 Million ≈ $139.32 Million |
€33.27 Million ≈ $38.90 Million |
0.279x | -- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more